]> C34.0 Main bronchus C34.1 Upper lobe, lung C34.2 Middle lobe, lung C34.3 Lower lobe, lung C34.8 Overlapping lesion of lung C34.9 Lung, NOS Note: Laterality must be coded for this site (except carina). CS Tumor Size Note 1: Do not code size of hilar mass unless primary is stated to be in the hilum. Code Description 000 No mass/tumor found 001-988 989 989 mm or larger 990 Microscopic focus or foci only and no size of focus given 991 Described as "less than 1 centimeter (cm)" 992 993 994 Described as "less than 4 cm," or "greater than 3 cm," or "between 3 cm and 4 cm" 995 Described as "less than 5 cm," or "greater than 4 cm," or "between 4 cm and 5 cm" 996 997 Diffuse (entire lobe) 998 Diffuse (entire lung or NOS) 999 CS Extension Note 1: Direct extension to or other involvement of structures considered M1 in AJCC staging is coded in the data item CS Mets at DX. This includes: sternum; skeletal muscle; skin of chest; contralateral lung or mainstem bronchus; separate tumor nodule(s) in contralateral lung. Note 2: Distance from Carina: Assume tumor is greater than or equal to 2 centimeters (cm) from carina if lobectomy, segmental resection, or wedge resection is done. Note 3: Opposite Lung: If no mention is made of the opposite lung on a chest x-ray, assume it is not involved. Note 4: Bronchopneumonia: Bronchopneumonia is not the same thing as obstructive pneumonitis and should not be coded as such. Bronchopneumonia is an acute inflammation of the walls of the bronchioles, usually a result of spread of infection from the upper to the lower respiratory tract. Obstructive pneumonitis is a combination of atelectasis, bronchiectasis with mucous plugging, and parenchymal inflammation that develops distal to an obstructing endobronchial lesion. Note 5: Pulmonary Artery/Vein: An involved pulmonary artery/vein in the mediastinum is coded to 700 (involvement of major blood vessel). However, if the involvement of the artery/vein appears to be only within lung tissue and not in the mediastinum, it is not coded to 700. Note 6: Vocal cord paralysis (resulting from involvement of recurrent branch of the vagus nerve), superior vena cava (SVC) obstruction, or compression of the trachea or the esophagus may be related to direct extension of the primary tumor or to lymph node involvement. The treatment options and prognosis associated with these manifestations of disease extent fall within the T4-Stage IIIB category; therefore, generally use code 700 for these manifestations. However, if the primary tumor is peripheral and clearly unrelated to vocal cord paralysis, SVC obstruction, or compression of the trachea or the esophagus, code these manifestations as mediastinal lymph node involvement (code 200) in CS Lymph Nodes, unless there is a statement of involvement by direct extension from the primary tumor. Note 7: Pleural effusion and pericardial effusion are coded in CS Mets at DX. Note 8: In some cases, the determination of the T category for TNM 6 or 7 staging is based on this field, CS Tumor Size, CS Mets at DX, and CS Site-Specific Factor 1. Note 9: Code to the highest applicable code for CS Extension and then code the absence or presence of separate ipsilateral tumor nodules in CS Site-Specific Factor 1, Separate Tumor Nodules/Ipsilateral lung. Code separate tumor nodules in contralateral lung in CS Mets at Dx. Note 10: Specific information about visceral pleura invasion is captured in codes 410-430 and CS Site-Specific Factor 2, Visceral Pleural Invasion (VPI)/Elastic Layer. Elastic layer involvement has prognostic significance for lung cancer. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 000 In situ, intraepithelial, noninvasive ^ * # ** 100 ^ * L ** 110 ^ * L ** 115 Stated as T1a with no other information on extension ^ * L ** 120 Stated as T1b with no other information on extension ^ * L ** 125 Stated as T1[NOS] with no other information on extension ^ * L ** 200 ^ * L ** 210 ^ * L ** 220 ^ * L ** 230 Tumor confined to hilus ^ * L ** 250 ERROR * ERROR ** 300 Localized, NOS ^ * L ** 400 ^ * RE ** 410 ^ * RE ** 420 Invasion of pleura, including invasion through the elastic layer ^ * RE ** 430 Invasion of pleura, NOS ^ * RE ** 440 Pulmonary ligament ^ * RE ** 450 ERROR * RE ** 455 Stated as T2a with no other information on extension ^ * RE ** 460 Stated as T2b with no other information on extension ^ * RE ** 465 Stated as T2 [NOS] with no other information on size or extension ^ * RE ** 500 ^ * L ** 520 500 + 400 ^ * RE ** 530 ERROR * RE ** 540 500 + any of (410-440) ^ * RE ** 550 Atelectasis/obstructive pneumonitis involving entire lung ^ * RE ** 560 Parietal pericardium or pericardium, NOS ^ * RE ** 570 Stated as T3 with no other information on extension ^ * RE ** 590 Invasion of phrenic nerve ^ * RE ** 600 ^ * D ** 610 T4 * D ** 650 ERROR * L ** 680 Tumor confined to carina T4 * L ** 700 T4 * RE ** 705 T4 * D D 710 T4 * D D 720 ERROR * D D 730 ^ * D D 740 Aorta T4 * D ** 745 740 + 710 T4 * D D 748 740 + 730 T4 * D D 750 T4 * D D 760 ERROR * D D 770 Inferior vena cava T4 * D D 780 ERROR * D D 785 T4 * D D 790 ERROR * D D 795 ERROR * ERROR ERROR 800 T4 * D D 810 Stated as T4 with no other information on extension T4 * D D 950 No evidence of primary tumor ^ * # ** 980 ^ * # ** 999 ^ * # ** ^ For CS Extension codes 000-440, 455-520, 540-600, 730, and 950-999, the T category for AJCC 7 staging is assigned based on the values of CS Tumor Size, CS Extension, and CS Site Specific Factor 1, as shown in the Size Extension AJCC 7 Table for this schema. * For CS Extension codes 000-999, the T category for AJCC 6 staging is assigned based on the values of CS Tumor Size, CS Extension, CS Mets at Dx and CS Site Specific Factor 1 as shown in the Size Extension Mets AJCC 6 Table for this schema. # For CS Extension codes 000, 950, 980 and 999, Summary Stage 77 is assigned based on the values of CS Extension and Site Specific Factor 1 as shown in the Summary Stage 77 Table for this schema. ** For CS Extension codes 000-700, 740, 950-999, Summary Stage 2000 is assigned based on the values of CS Extension and Site Specific Factor 1 as shown in the Summary Stage 2000 Table for this schema. CS Tumor Size/Ext Eval Code Description Staging Basis 7 Staging Basis 6 0 c c 1 c p 2 p p 3 p p 5 c c 6 yp yp 8 a a 9 c c CS Lymph Nodes Note 1: Code only regional nodes and nodes, NOS, in this field. Distant nodes are coded in CS Mets at DX. For illustration of nodes stations, see Part I. Note 2: If at mediastinoscopy/x-ray, the description is "mass", "adenopathy", or "enlargement" of any of the lymph nodes named as regional in codes 100 and 200, assume that at least regional lymph nodes are involved. If there is any mention of bilateral or contralateral mass, adenopathy or lymph node involvement , use code 600. Note 3: The words "no evidence of spread" or "remaining examination negative" are sufficient information to consider regional lymph nodes negative in the absence of any statement about nodes. Note 4: Vocal cord paralysis (resulting from involvement of the recurrent branch of the vagus nerve), superior vena cava (SVC) obstruction, or compression of the trachea or the esophagus, may be related to direct extension of the primary tumor or to lymph node involvement. The treatment options and prognosis associated with these manifestations of disease extent fall within the T4-Stage IIIB category; therefore, generally use CS Extension code 700 for these manifestations and not CS lymph nodes . However, if the primary tumor is peripheral and clearly unrelated to vocal cord paralysis, SVC obstruction, or compression of the trachea or the esophagus, code these manifestations as mediastinal lymph node involvement (code 200) in CS Lymph Nodes, unless there is a statement of involvement by direct extension from the primary tumor. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 000 No regional lymph node involvement N0 N0 NONE NONE 100 N1 N1 RN RN 200 N2 N2 RN RN 500 Regional lymph node(s), NOS N1 N1 RN RN 600 N3 N3 D D 800 Lymph nodes, NOS N1 N1 RN RN 999 NX NX U U CS Lymph Nodes Eval Note: This item reflects the validity of the classification of the item CS Lymph Nodes only according to diagnostic methods employed. Code Description Staging Basis 7 Staging Basis 6 0 c c 1 c p 2 p p 3 p p 5 c c 6 yp yp 8 a a 9 c c &generalreglnpos; &generalreglnexam; CS Mets at DX Note 1: Most pleural and pericardial effusions with lung cancer are due to tumor. In a few patients, however, multiple cytopathologic examinations of pleural and/or pericardial fluid are negative for tumor, and the fluid is nonbloody and is not an exudate. Where these elements and clinical judgment dictate that the effusion is not related to the tumor, the effusion should be excluded as a staging element and the tumor should be classified as M0. Note 2: For contralateral (different lung) pleural effusion, use code 16 instead of code 40. For bilateral (same and different lung) pleural effusion, use code 17 instead of code 40. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 00 No distant metastasis ^ * NONE NONE 10 ERROR * ERROR ERROR 15 Malignant pleural effusion, ipsilateral or same lung M1a * D D 16 Malignant pleural effusion, contralateral or other lung M1a * D D 17 Malignant pleural effusion, ipsilateral and contralateral lungs (Bilateral pleural effusion) M1a * D D 18 Malignant pleural effusion, unknown if ipsilateral or contralateral lung M1a * D D 20 Malignant pericardial effusion M1a * D D 21 M1a * D D 23 M1a * D D 24 Pleural tumor foci or nodules on the ipsilateral lung separate from direct invasion M1a * D D 25 M1a * D D 26 Stated as M1a with no other information on distant metastasis M1a * D D 30 Distant lymph node(s), including cervical nodes M1b * D D 32 M1b * D D 33 M1b * D D 35 ERROR * L D 36 M1b * D D 37 M1b * D D 38 M1b * D D 39 ERROR * ERROR ERROR 40 M1b * D D 41 M1b * D D 42 M1b * D D 43 M1b * D D 50 ERROR * D D 51 M1b * D D 52 M1b * D D 53 M1b * D D 70 Stated as M1b with no other information on distant metastasis M1b * D D 75 Stated as M1 [NOS] with no other information on distant metastasis M1NOS * D D 99 ^ * U U ^ For CS Mets at DX codes 00 and 99, the M category for AJCC 7 staging is assigned based on the value of CS Tumor Size as shown in the Size Mets at DX AJCC 7 Table for this schema. * For all CS Met at Dx codes, the M category for AJCC 6 staging is assigned based on the values of CS Tumor Size, CS Extension, CS Mets at DX, and CS Site Specific Factor 1, as shown in the Size Extension Mets SSF1 AJCC 6 Tables for this schema. &generalmetseval; CS Site-Specific Factor 1 Separate Tumor Nodules - Ipsilateral Lung Note 1: Separate tumor nodules in the ipsilateral lung are coded separately from CS Extension. Separate tumor nodules in the contralateral lung are coded in CS Mets at DX. Note 2: Separate tumor nodules can be defined clinically (by imaging) and/or pathologically. Note 3: If separate tumor nodules are not mentioned in imaging and/or pathological reports, use code 000. Code Description 000 No separate tumor nodules noted 010 Separate tumor nodules in ipsilateral lung, same lobe 020 Separate tumor nodules in ipsilateral lung, different lobe 030 040 Separate tumor nodules, ipsilateral lung, unknown if same or different lobe 888 988 999 CS Site-Specific Factor 2 Pleural/Elastic Layer Invasion (PL) by H and E or Elastic Stain Note 2: Code results as stated on the pathology report. Code 998 if no histologic examination of pleura to assess pleural layer invasion. Note 3: If pleural/elastic layer invasion (PL) is not mentioned on the pathology report, code 999. Note 4: An FNA is not a histologic specimen and is not adequate to assess pleural layer invasion. If only an FNA is available, use code 998. Note 5: Metastasis to the pleura, that is pleural tumor foci or nodules separate from direct invasion, are coded in CS Mets at Dx (code 24). Code Description 000 010 020 030 040 Invasion of pleura, NOS 888 988 998 No histologic examination of pleura to assess pleural layer invasion 999 ¬appssfactor3; ¬appssfactor4; ¬appssfactor5; ¬appssfactor6; ¬appnewssf7; ¬appnewssf8; ¬appnewssf9; ¬appnewssf10; ¬appnewssf11; ¬appnewssf12; ¬appnewssf13; ¬appnewssf14; ¬appnewssf15; ¬appnewssf16; ¬appnewssf17; ¬appnewssf18; ¬appnewssf19; ¬appnewssf20; ¬appnewssf21; ¬appnewssf22; ¬appnewssf23; ¬appnewssf24; ¬appnewssf25; &commonhistinclusioncarcinoma; Histology Exclusion Table AJCC 6th ed. Note: Histology codes listed in this Histology Exclusion Table for this site are codes that are not TNM staged according to the AJCC 6th Edition Cancer Staging Manual. When a case is coded in Collaborative Staging and the histology is on the exclusion list, TNM will not be calculated but SEER algorithm Summary Stage 1977 and 2000 can be assigned. For these cases, displayed results will be "T NA N NA M NA and Stage Group NA". Code Description 8240/1 Carcinoid tumor of uncertain malignant potential 8240/3 Carcinoid tumor, NOS (except of appendix M-8240/1) 8241/3 Enterochromaffin cell carcinoid 8242/1 Enterochromaffin-like cell carcinoid, NOS 8242/3 Enterochromaffin-like cell tumor, malignant 8243/3 Goblet cell carcinoid 8248/1 Apudoma 8680/0 Paraganglioma, benign 8680/1 Paraganglioma, NOS 8680/3 Paraganglioma, malignant 8681/1 Sympathetic paraganglioma 8682/1 Parasympathetic paraganglioma 8683/0 Gangliocytic paraganglioma (C17.0) 8690/1 Glomus jugulare tumor, NOS (C75.5) 8691/1 Aortic body tumor (C75.5) 8692/1 Carotid body tumor (C75.4) 8693/1 Extra-adrenal paraganglioma, NOS 8693/3 Extra-adrenal paraganglioma, malignant 8700/0 Pheochromocytoma, NOS (C74.1) 8700/3 Pheochromocytoma, malignant (C74.1) 8710/3 Glomangiosarcoma 8711/0 Glomus tumor, NOS 8711/3 Glomus tumor, malignant 8712/0 Glomangioma 8713/0 Glomangiomyoma 8800/0 Soft tissue tumor, benign 8800/3 Sarcoma, NOS 8800/9 Sarcomatosis, NOS 8801/3 Spindle cell sarcoma 8802/3 Giant cell sarcoma (except of bone M-9250/3) 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumor 8810/0 Fibroma, NOS 8810/1 Cellular fibroma (C56.9) 8810/3 Fibrosarcoma, NOS 8811/0 Fibromyxoma 8811/3 Fibromyxosarcoma 8812/0 Periosteal fibroma (C40._, C41._) 8812/3 Periosteal fibrosarcoma (C40._, C41._) 8813/0 Fascial fibroma 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/0 Solitary fibrous tumor 8815/3 Solitary fibrous tumor, malignant 8820/0 Elastofibroma 8821/1 Aggressive fibromatosis 8822/1 Abdominal fibromatosis 8823/0 Desmoplastic fibroma 8824/0 Myofibroma 8824/1 Myofibromatosis 8825/0 Myofibroblastoma 8825/1 Myofibroblastic tumor, NOS 8826/0 Angiomyofibroblastoma 8827/1 Myofibroblastic tumor, peribronchial (C34._) 8830/0 Benign fibrous histiocytoma 8830/1 Atypical fibrous histiocytoma 8830/3 Malignant fibrous histiocytoma 8831/0 Histiocytoma, NOS 8832/0 Dermatofibroma, NOS (C44._) 8832/3 Dermatofibrosarcoma, NOS (C44._) 8833/3 Pigmented dermatofibrosarcoma protuberans (C44._) 8834/1 Giant cell fibroblastoma 8835/1 Plexiform fibrohistiocytic tumor 8836/1 Angiomatoid fibrous histiocytoma 8840/0 Myxoma, NOS 8840/3 Myxosarcoma 8841/1 Angiomyxoma 8842/0 Ossifying fibromyxoid tumor 8850/0 Lipoma, NOS 8850/1 Atypical lipoma 8850/3 Liposarcoma, NOS 8851/0 Fibrolipoma 8851/3 Liposarcoma, well differentiated 8852/0 Fibromyxolipoma 8852/3 Myxoid liposarcoma 8853/3 Round cell liposarcoma 8854/0 Pleomorphic lipoma 8854/3 Pleomorphic liposarcoma 8855/3 Mixed liposarcoma 8856/0 Intramuscular lipoma 8857/0 Spindle cell lipoma 8857/3 Fibroblastic liposarcoma 8858/3 Dedifferentiated liposarcoma 8860/0 Angiomyolipoma 8861/0 Angiolipoma, NOS 8862/0 Chondroid lipoma 8870/0 Myelolipoma 8880/0 Hibernoma 8881/0 Lipoblastomatosis 8890/0 Leiomyoma, NOS 8890/1 Leiomyomatosis, NOS 8890/3 Leiomyosarcoma, NOS 8891/0 Epithelioid leiomyoma 8891/3 Epithelioid leiomyosarcoma 8892/0 Cellular leiomyoma 8893/0 Bizarre leiomyoma 8894/0 Angiomyoma 8894/3 Angiomyosarcoma 8895/0 Myoma 8895/3 Myosarcoma 8896/3 Myxoid leiomyosarcoma 8897/1 Smooth muscle tumor of uncertain malignant potential 8898/1 Metastasizing leiomyoma 8900/0 Rhabdomyoma, NOS 8900/3 Rhabdomyosarcoma, NOS 8901/3 Pleomorphic rhabdomyosarcoma, adult type 8902/3 Mixed type rhabdomyosarcoma 8903/0 Fetal rhabdomyoma 8904/0 Adult rhabdomyoma 8905/0 Genital rhabdomyoma (C51._, C52.9) 8910/3 Embryonal rhabdomyosarcoma, NOS 8912/3 Spindle cell rhabdomyosarcoma 8920/3 Alveolar rhabdomyosarcoma 8921/3 Rhabdomyosarcoma with ganglionic differentiation 8930/0 Endometrial stromal nodule (C54.1) 8930/3 Endometrial stromal sarcoma, NOS (C54.1) 8931/3 Endometrial stromal sarcoma, low grade (C54.1) 8932/0 Adenomyoma 8933/3 Adenosarcoma 8934/3 Carcinofibroma 8935/0 Stromal tumor, benign 8935/1 Stromal tumor, NOS 8935/3 Stromal sarcoma, NOS 8936/0 Gastrointestinal stromal tumor, benign 8936/1 Gastrointestinal stromal tumor, NOS 8936/3 Gastrointestinal stromal sarcoma 8950/3 Mullerian mixed tumor (C54._) 8951/3 Mesodermal mixed tumor 8959/0 Benign cystic nephroma (C64.9) 8959/1 Cystic partially differentiated nephroblastoma (C64.9) 8959/3 Malignant cystic nephroma (C64.9) 8960/1 Mesoblastic nephroma 8960/3 Nephroblastoma, NOS (C64.9) 8963/3 Malignant rhabdoid tumor 8964/3 Clear cell sarcoma of kidney (C64.9) 8965/0 Nephrogenic adenofibroma (C64.9) 8966/0 Renomedullary interstitial cell tumor (C64.9) 8967/0 Ossifying renal tumor (C64.9) 8970/3 Hepatoblastoma (C22.0) 8971/3 Pancreatoblastoma (C25._) 8972/3 Pulmonary blastoma (C34._) 8973/3 Pleuropulmonary blastoma 8974/1 Sialoblastoma 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal 8982/0 Myoepithelioma 8982/3 Malignant myoepithelioma 8983/0 Adenomyoepithelioma (C50._) 8990/0 Mesenchymoma, benign 8990/1 Mesenchymoma, NOS 8990/3 Mesenchymoma, malignant 8991/3 Embryonal sarcoma 9000/0 Brenner tumor, NOS (C56.9) 9000/1 Brenner tumor, borderline malignancy (C56.9) 9000/3 Brenner tumor, malignant (C56.9) 9010/0 Fibroadenoma, NOS (C50._) 9011/0 Intracanalicular fibroadenoma (C50._) 9012/0 Pericanalicular fibroadenoma (C50._) 9013/0 Adenofibroma, NOS 9014/0 Serous adenofibroma, NOS 9014/1 Serous adenofibroma of borderline malignancy 9014/3 Serous adenocarcinofibroma 9015/0 Mucinous adenofibroma, NOS 9015/1 Mucinous adenofibroma of borderline malignancy 9015/3 Mucinous adenocarcinofibroma 9016/0 Giant fibroadenoma (C50._) 9020/0 Phyllodes tumor, benign (C50._) 9020/1 Phyllodes tumor, borderline (C50._) 9020/3 Phyllodes tumor, malignant (C50._) 9030/0 Juvenile fibroadenoma (C50._) 9040/0 Synovioma, benign 9040/3 Synovial sarcoma, NOS 9041/3 Synovial sarcoma, spindle cell 9042/3 Synovial sarcoma, epithelioid cell 9043/3 Synovial sarcoma, biphasic 9044/3 Clear cell sarcoma, NOS (except of kidney M-8964/3) 9050/0 Mesothelioma, benign 9050/3 Mesothelioma, malignant 9051/0 Fibrous mesothelioma, benign 9051/3 Fibrous mesothelioma, malignant 9052/0 Epithelioid mesothelioma, benign 9052/3 Epithelioid mesothelioma, malignant 9053/3 Mesothelioma, biphasic, malignant 9054/0 Adenomatoid tumor, NOS 9055/0 Multicystic mesothelioma, benign 9055/1 Cystic mesothelioma, NOS (C48._) 9060/3 Dysgerminoma 9061/3 Seminoma, NOS (C62._) 9062/3 Seminoma, anaplastic (C62._) 9063/3 Spermatocytic seminoma (C62._) 9064/2 Intratubular malignant germ cells (C62._) 9064/3 Germinoma 9065/3 Germ cell tumor, nonseminomatous (C62._) 9070/3 Embryonal carcinoma, NOS 9071/3 Yolk sac tumor 9072/3 Polyembryoma 9073/1 Gonadoblastoma 9080/0 Teratoma, benign 9080/1 Teratoma, NOS 9080/3 Teratoma, malignant, NOS 9081/3 Teratocarcinoma 9082/3 Malignant teratoma, undifferentiated 9083/3 Malignant teratoma, intermediate 9084/0 Dermoid cyst, NOS 9084/3 Teratoma with malignant transformation 9085/3 Mixed germ cell tumor 9090/0 Struma ovarii, NOS (C56.9) 9090/3 Struma ovarii, malignant (C56.9) 9091/1 Strumal carcinoid (C56.9) 9100/0 Hydatidiform mole, NOS (C58.9) 9100/1 Invasive hydatidiform mole (C58.9) 9100/3 Choriocarcinoma, NOS 9101/3 Choriocarcinoma combined with other germ cell elements 9102/3 Malignant teratoma, trophoblastic 9103/0 Partial hydatidiform mole (C58.9) 9104/1 Placental site trophoblastic tumor (C58.9) 9105/3 Trophoblastic tumor, epithelioid 9110/0 Mesonephroma, benign 9110/1 Mesonephric tumor, NOS 9110/3 Mesonephroma, malignant 9120/0 Hemangioma, NOS 9120/3 Hemangiosarcoma 9121/0 Cavernous hemangioma 9122/0 Venous hemangioma 9123/0 Racemose hemangioma 9124/3 Kupffer cell sarcoma (C22.0) 9125/0 Epithelioid hemangioma 9130/0 Hemangioendothelioma, benign 9130/1 Hemangioendothelioma, NOS 9130/3 Hemangioendothelioma, malignant 9131/0 Capillary hemangioma 9132/0 Intramuscular hemangioma 9133/1 Epithelioid hemangioendothelioma, NOS 9133/3 Epithelioid hemangioendothelioma, malignant 9135/1 Endovascular papillary angioendothelioma 9136/1 Spindle cell hemangioendothelioma 9140/3 Kaposi sarcoma 9141/0 Angiokeratoma 9142/0 Verrucous keratotic hemangioma 9150/0 Hemangiopericytoma, benign 9150/1 Hemangiopericytoma, NOS 9150/3 Hemangiopericytoma, malignant 9160/0 Angiofibroma, NOS 9161/0 Acquired tufted hemangioma 9161/1 Hemangioblastoma 9170/0 Lymphangioma, NOS 9170/3 Lymphangiosarcoma 9171/0 Capillary lymphangioma 9172/0 Cavernous lymphangioma 9173/0 Cystic lymphangioma 9174/0 Lymphangiomyoma 9174/1 Lymphangiomyomatosis 9175/0 Hemolymphangioma 9180/0 Osteoma, NOS (C40._, C41._) 9180/3 Osteosarcoma, NOS (C40._, C41._) 9181/3 Chondroblastic osteosarcoma (C40._, C41._) 9182/3 Fibroblastic osteosarcoma (C40._, C41._) 9183/3 Telangiectatic osteosarcoma (C40._, C41._) 9184/3 Osteosarcoma in Paget disease of bone (C40._, C41._) 9185/3 Small cell osteosarcoma (C40._, C41._) 9186/3 Central osteosarcoma (C40._, C41._) 9187/3 Intraosseous well differentiated osteosarcoma (C40._, C41._) 9191/0 Osteoid osteoma, NOS (C40._, C41._) 9192/3 Parosteal osteosarcoma (C40._, C41._) 9193/3 Periosteal osteosarcoma (C40._, C41._) 9194/3 High grade surface osteosarcoma (C40._, C41._) 9195/3 Intracortical osteosarcoma (C40._, C41._) 9200/0 Osteoblastoma, NOS (C40._, C41._) 9200/1 Aggressive osteoblastoma (C40._, C41._) 9210/0 Osteochondroma (C40._, C41._) 9210/1 Osteochondromatosis, NOS (C40._, C41._) 9220/0 Chondroma, NOS (C40._, C41._) 9220/1 Chondromatosis, NOS 9220/3 Chondrosarcoma, NOS (C40._, C41._) 9221/0 Juxtacortical chondroma (C40._, C41._) 9221/3 Juxtacortical chondrosarcoma (C40._, C41._) 9230/0 Chondroblastoma, NOS (C40._, C41._) 9230/3 Chondroblastoma, malignant (C40._, C41._) 9231/3 Myxoid chondrosarcoma 9240/3 Mesenchymal chondrosarcoma 9241/0 Chondromyxoid fibroma (C40._, C41._) 9242/3 Clear cell chondrosarcoma (C40._, C41._) 9243/3 Dedifferentiated chondrosarcoma (C40._, C41._) 9250/1 Giant cell tumor of bone, NOS (C40._, C41._) 9250/3 Giant cell tumor of bone, malignant (C40._, C41._) 9251/1 Giant cell tumor of soft parts, NOS 9251/3 Malignant giant cell tumor of soft parts 9252/0 Tenosynovial giant cell tumor (C49._) 9252/3 Malignant tenosynovial giant cell tumor (C49._) 9260/3 Ewing sarcoma 9261/3 Adamantinoma of long bones (C40._) 9262/0 Ossifying fibroma 9270/0 Odontogenic tumor, benign 9270/1 Odontogenic tumor, NOS 9270/3 Odontogenic tumor, malignant 9271/0 Ameloblastic fibrodentinoma 9272/0 Cementoma, NOS 9273/0 Cementoblastoma, benign 9274/0 Cementifying fibroma 9275/0 Gigantiform cementoma 9280/0 Odontoma, NOS 9281/0 Compound odontoma 9282/0 Complex odontoma 9290/0 Ameloblastic fibro-odontoma 9290/3 Ameloblastic odontosarcoma 9300/0 Adenomatoid odontogenic tumor 9301/0 Calcifying odontogenic cyst 9302/0 Odontogenic ghost cell tumor 9310/0 Ameloblastoma, NOS 9310/3 Ameloblastoma, malignant 9311/0 Odontoameloblastoma 9312/0 Squamous odontogenic tumor 9320/0 Odontogenic myxoma 9321/0 Central odontogenic fibroma 9322/0 Peripheral odontogenic fibroma 9330/0 Ameloblastic fibroma 9330/3 Ameloblastic fibrosarcoma 9340/0 Calcifying epithelial odontogenic tumor 9341/1 Clear cell odontogenic tumor 9342/3 Odontogenic carcinosarcoma 9350/1 Craniopharyngioma (C75.2) 9351/1 Craniopharyngioma, adamantinomatous (C75.2) 9352/1 Craniopharyngioma, papillary (C75.2) 9360/1 Pinealoma (C75.3) 9361/1 Pineocytoma (C75.3) 9362/3 Pineoblastoma (C75.3) 9363/0 Melanotic neuroectodermal tumor 9364/3 Peripheral neuroectodermal tumor 9365/3 Askin tumor 9370/3 Chordoma, NOS 9371/3 Chondroid chordoma 9372/3 Dedifferentiated chordoma 9373/0 Parachordoma 9380/3 Glioma, malignant (C71._) 9381/3 Gliomatosis cerebri (C71._) 9382/3 Mixed glioma (C71._) 9383/1 Subependymoma (C71._) 9384/1 Subependymal giant cell astrocytoma (C71._) 9390/0 Choroid plexus papilloma, NOS (C71.5) 9390/1 Atypical choroid plexus papilloma (C71.5) 9390/3 Choroid plexus carcinoma (C71.5) 9391/3 Ependymoma, NOS (C71._) 9392/3 Ependymoma, anaplastic (C71._) 9393/3 Papillary ependymoma (C71._) 9394/1 Myxopapillary ependymoma (C72.0) 9400/3 Astrocytoma, NOS (C71._) 9401/3 Astrocytoma, anaplastic (C71._) 9410/3 Protoplasmic astrocytoma (C71._) 9411/3 Gemistocytic astrocytoma (C71._) 9412/1 Desmoplastic infantile astrocytoma (C71._) 9413/0 Dysembryoplastic neuroepithelial tumor 9420/3 Fibrillary astrocytoma (C71._) 9421/1 Pilocytic astrocytoma (C71._) 9423/3 Polar spongioblastoma (C71._) 9424/3 Pleomorphic xanthoastrocytoma (C71._) 9430/3 Astroblastoma (C71._) 9440/3 Glioblastoma, NOS (C71._) 9441/3 Giant cell glioblastoma (C71._) 9442/1 Gliofibroma (C71._) 9442/3 Gliosarcoma (C71._) 9444/1 Chordoid glioma (C71._) 9450/3 Oligodendroglioma, NOS (C71._) 9451/3 Oligodendroglioma, anaplastic (C71._) 9460/3 Oligodendroblastoma (C71._) [obs] 9470/3 Medulloblastoma, NOS (C71.6) 9471/3 Desmoplastic nodular medulloblastoma (C71.6) 9472/3 Medullomyoblastoma (C71.6) 9473/3 Primitive neuroectodermal tumor, NOS 9474/3 Large cell medulloblastoma (C71.6) 9480/3 Cerebellar sarcoma, NOS (C71.6) [obs] 9490/0 Ganglioneuroma 9490/3 Ganglioneuroblastoma 9491/0 Ganglioneuromatosis 9492/0 Gangliocytoma 9493/0 Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) (C71.6) 9500/3 Neuroblastoma, NOS 9501/0 Medulloepithelioma, benign (C69.4) 9501/3 Medulloepithelioma, NOS 9502/0 Teratoid medulloepithelioma, benign (C69.4) 9502/3 Teratoid medulloepithelioma 9503/3 Neuroepithelioma, NOS 9504/3 Spongioneuroblastoma 9505/1 Ganglioglioma, NOS 9505/3 Ganglioglioma, anaplastic 9506/1 Central neurocytoma 9507/0 Pacinian tumor 9508/3 Atypical teratoid/rhabdoid tumor (C71._) 9510/0 Retinocytoma (C69.2) 9510/3 Retinoblastoma, NOS (C69.2) 9511/3 Retinoblastoma, differentiated (C69.2) 9512/3 Retinoblastoma, undifferentiated (C69.2) 9513/3 Retinoblastoma, diffuse (C69.2) 9514/1 Retinoblastoma, spontaneously regressed (C69.2) 9520/3 Olfactory neurogenic tumor 9521/3 Olfactory neurocytoma (C30.0) 9522/3 Olfactory neuroblastoma (C30.0) 9523/3 Olfactory neuroepithelioma (C30.0) 9530/0 Meningioma, NOS 9530/1 Meningiomatosis, NOS 9530/3 Meningioma, malignant 9531/0 Meningothelial meningioma 9532/0 Fibrous meningioma 9533/0 Psammomatous meningioma 9534/0 Angiomatous meningioma 9535/0 Hemangioblastic meningioma [obs] 9537/0 Transitional meningioma 9538/1 Clear cell meningioma 9538/3 Papillary meningioma 9539/1 Atypical meningioma 9539/3 Meningeal sarcomatosis 9540/0 Neurofibroma, NOS 9540/1 Neurofibromatosis, NOS 9540/3 Malignant peripheral nerve sheath tumor 9541/0 Melanotic neurofibroma 9550/0 Plexiform neurofibroma 9560/0 Neurilemoma, NOS 9560/1 Neurinomatosis 9560/3 Neurilemoma, malignant [obs] 9561/3 Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation 9562/0 Neurothekeoma 9570/0 Neuroma, NOS 9571/0 Perineurioma, NOS 9571/3 Perineurioma, malignant 9580/0 Granular cell tumor, NOS 9580/3 Granular cell tumor, malignant 9581/3 Alveolar soft part sarcoma 9582/0 Granular cell tumor of the sellar region (C75.1) 9590/3 Malignant lymphoma, NOS 9591/3 Malignant lymphoma, non-Hodgkin, NOS 9596/3 Composite Hodgkin and non-Hodgkin lymphoma 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocyte depletion, NOS 9654/3 Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyte depletion, reticular 9659/3 Hodgkin lymphoma, nodular lymphocyte predominance 9661/3 Hodgkin granuloma [obs] 9662/3 Hodgkin sarcoma [obs] 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nodular sclerosis, cellular phase 9665/3 Hodgkin lymphoma, nodular sclerosis, grade 1 9667/3 Hodgkin lymphoma, nodular sclerosis, grade 2 9670/3 Malignant lymphoma, small B lymphocytic, NOS (see also M-9823/3) 9671/3 Malignant lymphoma, lymphoplasmacytic (see also M-9761/3) 9673/3 Mantle cell lymphoma 9675/3 Malignant lymphoma, mixed small and large cell, diffuse [obs] (see also M-9690/3) 9678/3 Primary effusion lymphoma 9679/3 Mediastinal large B-cell lymphoma (C38.3) 9680/3 Malignant lymphoma, large B-cell, diffuse, NOS 9684/3 Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS (see also M-9826/3) 9689/3 Splenic marginal zone B-cell lymphoma (C42.2) 9690/3 Follicular lymphoma, NOS (see also M-9675/3) 9691/3 Follicular lymphoma, grade 2 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS 9700/3 Mycosis fungoides (C44._) 9701/3 Sezary syndrome 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma 9708/3 Subcutaneous panniculitis-like T-cell lymphoma 9709/3 Cutaneous T-cell lymphoma, NOS (C44._) 9714/3 Anaplastic large cell lymphoma, T cell and Null cell type 9716/3 Hepatosplenic ?? (gamma-delta) cell lymphoma 9717/3 Intestinal T-cell lymphoma 9718/3 Primary cutaneous CD30+ T-cell lymphoproliferative disorder (C44._) 9719/3 NK/T-cell lymphoma, nasal and nasal-type 9727/3 Precursor cell lymphoblastic lymphoma, NOS (see also M-9835/3) 9728/3 Precursor B-cell lymphoblastic lymphoma (see also M-9836/3) 9729/3 Precursor T-cell lymphoblastic lymphoma (see also M-9837/3) 9731/3 Plasmacytoma, NOS 9732/3 Multiple myeloma (C42.1) 9733/3 Plasma cell leukemia (C42.1) 9734/3 Plasmacytoma, extramedullary (not occurring in bone) 9740/1 Mastocytoma, NOS 9740/3 Mast cell sarcoma 9741/3 Malignant mastocytosis 9742/3 Mast cell leukemia (C42.1) 9750/3 Malignant histiocytosis 9751/1 Langerhans cell histiocytosis, NOS 9752/1 Langerhans cell histiocytosis, unifocal 9753/1 Langerhans cell histiocytosis, multifocal 9754/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9760/3 Immunoproliferative disease, NOS 9761/3 Waldenstrom macroglobulinemia (C42.0) (see also M-9671/3) 9762/3 Heavy chain disease, NOS 9764/3 Immunoproliferative small intestinal disease (C17._) 9765/1 Monoclonal gammopathy of undetermined significance 9766/1 Angiocentric immunoproliferative lesion 9767/1 Angioimmunoblastic lymphadenopathy 9768/1 T-gamma lymphoproliferative disease 9769/1 Immunoglobulin deposition disease 9800/3 Leukemia, NOS 9801/3 Acute leukemia, NOS 9805/3 Acute biphenotypic leukemia 9820/3 Lymphoid leukemia, NOS 9823/3 B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (see also M-9670/3) 9826/3 Burkitt cell leukemia (see also M-9687/3) 9827/3 Adult T-cell leukemia/lymphoma (HTLV-1 positive) Includes all variants 9831/1 T-cell large granular lymphocytic leukemia 9832/3 Prolymphocytic leukemia, NOS 9833/3 Prolymphocytic leukemia, B-cell type 9834/3 Prolymphocytic leukemia, T-cell type 9835/3 Precursor cell lymphoblastic leukemia, NOS (see also M-9727/3) 9836/3 Precursor B-cell lymphoblastic leukemia (see also M-9728/3) 9837/3 Precursor T-cell lymphoblastic leukemia (see also M-9729/3) 9840/3 Acute myeloid leukemia, M6 type 9860/3 Myeloid leukemia, NOS 9861/3 Acute myeloid leukemia, NOS (FAB or WHO type not specified) (see also M-9930/3) 9863/3 Chronic myeloid leukemia, NOS 9866/3 Acute promyelocytic leukemia, t(15;17)(q22;q11-12) 9867/3 Acute myelomonocytic leukemia 9870/3 Acute basophilic leukemia 9871/3 Acute myeloid leukemia with abnormal marrow eosinophils Includes all variants 9872/3 Acute myeloid leukemia, minimal differentiation 9873/3 Acute myeloid leukemia without maturation 9874/3 Acute myeloid leukemia with maturation 9875/3 Chronic myelogenous leukemia, BCR/ABL positive 9876/3 Atypical chronic myeloid leukemia, BCR/ABL negative 9891/3 Acute monocytic leukemia 9895/3 Acute myeloid leukemia with multilineage dysplasia 9896/3 Acute myeloid leukemia, t(8;21)(q22;q22) 9897/3 Acute myeloid leukemia, 11q23 abnormalities 9910/3 Acute megakaryoblastic leukemia 9920/3 Therapy-related acute myeloid leukemia, NOS 9930/3 Myeloid sarcoma (see also M-9861/3) 9931/3 Acute panmyelosis with myelofibrosis (C42.1) 9940/3 Hairy cell leukemia (C42.1) 9945/3 Chronic myelomonocytic leukemia, NOS 9946/3 Juvenile myelomonocytic leukemia 9948/3 Aggressive NK-cell leukemia 9950/3 Polycythemia vera 9960/3 Chronic myeloproliferative disease, NOS 9961/3 Myelosclerosis with myeloid metaplasia 9962/3 Essential thrombocythemia 9963/3 Chronic neutrophilic leukemia 9964/3 Hypereosinophilic syndrome 9970/1 Lymphoproliferative disorder, NOS 9975/1 Myeloproliferative disease, NOS 9980/3 Refractory anemia 9982/3 Refractory anemia with sideroblasts 9983/3 Refractory anemia with excess blasts 9984/3 Refractory anemia with excess blasts in transformation [obs] 9985/3 Refractory cytopenia with multilineage dysplasia 9986/3 Myelodysplastic syndrome with 5q deletion (5q-) syndrome 9987/3 Therapy-related myelodysplastic syndrome, NOS 9989/3 Myelodysplastic syndrome, NOS AJCC TNM 7 Stage T N M Stage T0 N0 M0 ERROR T0 N1 M0 UNK T0 N2 M0 III T0 N3 M0 IIIB T0 NX M0 UNK Tis N0 M0 0 Tis N1 M0 ERROR Tis N2 M0 ERROR Tis N3 M0 ERROR Tis NX M0 0 T1a N0 M0 IA T1a N1 M0 IIA T1a N2 M0 IIIA T1a N3 M0 IIIB T1a NX M0 UNK T1b N0 M0 IA T1b N1 M0 IIA T1b N2 M0 IIIA T1b N3 M0 IIIB T1b NX M0 UNK T1NOS N0 M0 IA T1NOS N1 M0 IIA T1NOS N2 M0 IIIA T1NOS N3 M0 IIIB T1NOS NX M0 UNK T2a N0 M0 IB T2a N1 M0 IIA T2a N2 M0 IIIA T2a N3 M0 IIIB T2a NX M0 UNK T2b N0 M0 IIA T2b N1 M0 IIB T2b N2 M0 IIIA T2b N3 M0 IIIB T2b NX M0 UNK T2NOS N0 M0 UNK T2NOS N1 M0 II T2NOS N2 M0 IIIA T2NOS N3 M0 IIIB T2NOS NX M0 UNK T3 N0 M0 IIB T3 N1 M0 IIIA T3 N2 M0 IIIA T3 N3 M0 IIIB T3 NX M0 UNK T4 N0 M0 IIIA T4 N1 M0 IIIA T4 N2 M0 IIIB T4 N3 M0 IIIB T4 NX M0 III TX N0 M0 OCCULT TX N1 M0 UNK TX N2 M0 III TX N3 M0 IIIB TX NX M0 UNK T0 N0 M1a IV T0 N1 M1a IV T0 N2 M1a IV T0 N3 M1a IV T0 NX M1a IV Tis N0 M1a ERROR Tis N1 M1a ERROR Tis N2 M1a ERROR Tis N3 M1a ERROR Tis NX M1a ERROR T1a N0 M1a IV T1a N1 M1a IV T1a N2 M1a IV T1a N3 M1a IV T1a NX M1a IV T1b N0 M1a IV T1b N1 M1a IV T1b N2 M1a IV T1b N3 M1a IV T1b NX M1a IV T1NOS N0 M1a IV T1NOS N1 M1a IV T1NOS N2 M1a IV T1NOS N3 M1a IV T1NOS NX M1a IV T2a N0 M1a IV T2a N1 M1a IV T2a N2 M1a IV T2a N3 M1a IV T2a NX M1a IV T2b N0 M1a IV T2b N1 M1a IV T2b N2 M1a IV T2b N3 M1a IV T2b NX M1a IV T2NOS N0 M1a IV T2NOS N1 M1a IV T2NOS N2 M1a IV T2NOS N3 M1a IV T2NOS NX M1a IV T3 N0 M1a IV T3 N1 M1a IV T3 N2 M1a IV T3 N3 M1a IV T3 NX M1a IV T4 N0 M1a IV T4 N1 M1a IV T4 N2 M1a IV T4 N3 M1a IV T4 NX M1a IV TX N0 M1a IV TX N1 M1a IV TX N2 M1a IV TX N3 M1a IV TX NX M1a IV T0 N0 M1b IV T0 N1 M1b IV T0 N2 M1b IV T0 N3 M1b IV T0 NX M1b IV Tis N0 M1b ERROR Tis N1 M1b ERROR Tis N2 M1b ERROR Tis N3 M1b ERROR Tis NX M1b ERROR T1a N0 M1b IV T1a N1 M1b IV T1a N2 M1b IV T1a N3 M1b IV T1a NX M1b IV T1b N0 M1b IV T1b N1 M1b IV T1b N2 M1b IV T1b N3 M1b IV T1b NX M1b IV T1NOS N0 M1b IV T1NOS N1 M1b IV T1NOS N2 M1b IV T1NOS N3 M1b IV T1NOS NX M1b IV T2a N0 M1b IV T2a N1 M1b IV T2a N2 M1b IV T2a N3 M1b IV T2a NX M1b IV T2b N0 M1b IV T2b N1 M1b IV T2b N2 M1b IV T2b N3 M1b IV T2b NX M1b IV T2NOS N0 M1b IV T2NOS N1 M1b IV T2NOS N2 M1b IV T2NOS N3 M1b IV T2NOS NX M1b IV T3 N0 M1b IV T3 N1 M1b IV T3 N2 M1b IV T3 N3 M1b IV T3 NX M1b IV T4 N0 M1b IV T4 N1 M1b IV T4 N2 M1b IV T4 N3 M1b IV T4 NX M1b IV TX N0 M1b IV TX N1 M1b IV TX N2 M1b IV TX N3 M1b IV TX NX M1b IV T0 N0 M1NOS IV T0 N1 M1NOS IV T0 N2 M1NOS IV T0 N3 M1NOS IV T0 NX M1NOS IV Tis N0 M1NOS ERROR Tis N1 M1NOS ERROR Tis N2 M1NOS ERROR Tis N3 M1NOS ERROR Tis NX M1NOS ERROR T1a N0 M1NOS IV T1a N1 M1NOS IV T1a N2 M1NOS IV T1a N3 M1NOS IV T1a NX M1NOS IV T1b N0 M1NOS IV T1b N1 M1NOS IV T1b N2 M1NOS IV T1b N3 M1NOS IV T1b NX M1NOS IV T1NOS N0 M1NOS IV T1NOS N1 M1NOS IV T1NOS N2 M1NOS IV T1NOS N3 M1NOS IV T1NOS NX M1NOS IV T2a N0 M1NOS IV T2a N1 M1NOS IV T2a N2 M1NOS IV T2a N3 M1NOS IV T2a NX M1NOS IV T2b N0 M1NOS IV T2b N1 M1NOS IV T2b N2 M1NOS IV T2b N3 M1NOS IV T2b NX M1NOS IV T2NOS N0 M1NOS IV T2NOS N1 M1NOS IV T2NOS N2 M1NOS IV T2NOS N3 M1NOS IV T2NOS NX M1NOS IV T3 N0 M1NOS IV T3 N1 M1NOS IV T3 N2 M1NOS IV T3 N3 M1NOS IV T3 NX M1NOS IV T4 N0 M1NOS IV T4 N1 M1NOS IV T4 N2 M1NOS IV T4 N3 M1NOS IV T4 NX M1NOS IV TX N0 M1NOS IV TX N1 M1NOS IV TX N2 M1NOS IV TX N3 M1NOS IV TX NX M1NOS IV AJCC TNM 6 Stage T N M Stage T0 N0 M0 ERROR T0 N1 M0 IIA T0 N2 M0 IIIA T0 N3 M0 IIIB T0 NX M0 UNK T0 N0 M1 IV T0 N1 M1 IV T0 N2 M1 IV T0 N3 M1 IV T0 NX M1 IV T0 N0 MX UNK T0 N1 MX UNK T0 N2 MX UNK T0 N3 MX UNK T0 NX MX UNK Tis N0 M0 0 Tis N1 M0 ERROR Tis N2 M0 ERROR Tis N3 M0 ERROR Tis NX M0 0 Tis N0 M1 ERROR Tis N1 M1 ERROR Tis N2 M1 ERROR Tis N3 M1 ERROR Tis NX M1 ERROR Tis N0 MX 0 Tis N1 MX ERROR Tis N2 MX ERROR Tis N3 MX ERROR Tis NX MX 0 T1 N0 M0 IA T1 N1 M0 IIA T1 N2 M0 IIIA T1 N3 M0 IIIB T1 NX M0 UNK T1 N0 M1 IV T1 N1 M1 IV T1 N2 M1 IV T1 N3 M1 IV T1 NX M1 IV T1 N0 MX UNK T1 N1 MX UNK T1 N2 MX UNK T1 N3 MX UNK T1 NX MX UNK T2 N0 M0 IB T2 N1 M0 IIB T2 N2 M0 IIIA T2 N3 M0 IIIB T2 NX M0 UNK T2 N0 M1 IV T2 N1 M1 IV T2 N2 M1 IV T2 N3 M1 IV T2 NX M1 IV T2 N0 MX UNK T2 N1 MX UNK T2 N2 MX UNK T2 N3 MX UNK T2 NX MX UNK T3 N0 M0 IIB T3 N1 M0 IIIA T3 N2 M0 IIIA T3 N3 M0 IIIB T3 NX M0 UNK T3 N0 M1 IV T3 N1 M1 IV T3 N2 M1 IV T3 N3 M1 IV T3 NX M1 IV T3 N0 MX UNK T3 N1 MX UNK T3 N2 MX UNK T3 N3 MX UNK T3 NX MX UNK T4 N0 M0 IIIB T4 N1 M0 IIIB T4 N2 M0 IIIB T4 N3 M0 IIIB T4 NX M0 IIIB T4 N0 M1 IV T4 N1 M1 IV T4 N2 M1 IV T4 N3 M1 IV T4 NX M1 IV T4 N0 MX UNK T4 N1 MX UNK T4 N2 MX UNK T4 N3 MX UNK T4 NX MX UNK TX N0 M0 OCCULT TX N1 M0 UNK TX N2 M0 IIIA TX N3 M0 IIIB TX NX M0 UNK TX N0 M1 IV TX N1 M1 IV TX N2 M1 IV TX N3 M1 IV TX NX M1 IV TX N0 MX UNK TX N1 MX UNK TX N2 MX UNK TX N3 MX UNK TX NX MX UNK &commonsummarystage; Extension Mets SSF1 AJCC 6 Table CS SSF1 888 with CS Extension and CS Mets at DX Note: When CS Site-Specific Factor 1 is coded 888, OBSOLETE not applicable code, the T and M categories for AJCC 6 staging result in ERROR as shown in this table. CS Extension CS Mets at DX 00-99 0 99 000-999 ERROR ERROR Size Extension Mets SSF1 AJCC 6 Table CS SSF1 010 or 040 with CS Mets at DX and CS Tumor Size Note: When CS Site-Specific Factor 1 is coded 010 or 040, separate tumor nodules in same lobe or unknown if in same lobe, the values of T and M for AJCC 6 staging are assigned on the basis of CS Tumor Size and CS Mets at DX as shown in this table. CS Site-Specific Factor 1 codes 010 and 040 map to T4 in AJCC 6 staging. CS Tumor Size code 998 maps to M1. CS Tumor Size CS Mets at DX 00, 15, 18, 20, 24 CS Mets at DX 10, 39 CS Mets at DX 16, 17, 21, 23, 25-33, 35-38, 40-43, 50-75 CS Mets at DX 99 000-997, 999 T4 M0 T4 ERROR T4 M1 T4 MX 998 T4 M1 T4 ERROR T4 M1 T4 M1 Size Extension Mets SSF1 AJCC 6 Table CS SSF1 030 with CS Tumor Size and CS Extension Note: When CS Site-Specific Factor 1 is coded 030, separate tumor nodules in same and different lobes, the values of T and M for AJCC 6 staging are assigned as shown in this table. CS Site-Specific Factor 1 code 030 maps to T4 M1 in AJCC 6 staging for all CS Extension and CS Tumor Size values. CS Extension CS Tumor Size 000-999 0 999 000-230, 300-790, 800-999 T4 M1 250, 795 ERROR M1 Size Extension Mets SSF1 AJCC 6 Table CS SSF1 020 with CS Tumor Size and CS Extension Note: When CS Site-Specific Factor 1 is coded 020, separate tumor nodules in ipsilateral lung, different lobe, the values of T and M for AJCC 6 staging are assigned as shown in this table. The T category is determined by the CS Tumor Size and CS Extension codes. CS Site-Specific Factor 1 code 020 maps to M1 in AJCC 6 staging. CS Tumor Size codes 997, diffuse involvement of lobe, and 998, diffuse involvement of the entire lung, both map to T4. CS Extension CS Tumor Size 000 0 CS Tumor Size 001-030 1 30 CS Tumor Size 031-989 31 989 CS Tumor Size 990-993 990 993 CS Tumor Size 994-995 994 995 CS Tumor Size 996 996 CS Tumor Size 997-998 997 998 CS Tumor Size 999 999 000 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 100, 115-125, 230, 300 ERROR M1 T1 M1 T2 M1 T1 M1 T2 M1 TX M1 T4 M1 TX M1 110 ERROR M1 T1 M1 T1 M1 T1 M1 T1 M1 TX M1 T4 M1 T1 M1 200-220, 400-465 ERROR M1 T2 M1 T2 M1 T2 M1 T2 M1 TX M1 T4 M1 T2 M1 250 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 500-600, 730 ERROR M1 T3 M1 T3 M1 T3 M1 T3 M1 TX M1 T4 M1 T3 M1 610-720, 740-790 ERROR M1 T4 M1 T4 M1 T4 M1 T4 M1 TX M1 T4 M1 T4 M1 795 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 800-810 ERROR M1 T4 M1 T4 M1 T4 M1 T4 M1 TX M1 T4 M1 T4 M1 950 T0 M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 980-999 ERROR M1 TX M1 TX M1 TX M1 TX M1 TX M1 T4 M1 TX M1 Size Extension Mets SSF1 AJCC 6 Table CS SSF1 000, 988, or 999, CS Mets at DX 00 with CS Tumor Size and CS Extension Note: When CS Site-Specific Factor 1 is coded 000, 988, or 999, no separate tumor nodules in the primary site, unknown if separate nodules, or information not collected, and CS Mets at DX is coded 00, no distant metastases and no pleural foci or pleural effusion or pericardial effusion, the values of the T and M for AJCC 6 staging are assigned as shown in this table. The T category is determined by the CS Tumor Size and CS Extension codes. The CS Site-Specific Factor 1 and CS Mets at DX codes map to M0 in AJCC 6 staging. CS Tumor Size codes 997, diffuse involvement of lobe, and 998, diffuse involvement of the entire lung, both map to T4; code 998 also maps to M1. CS Extension CS Tumor Size 000 0 CS Tumor Size 001-030 1 30 CS Tumor Size 031-989 31 989 CS Tumor Size 990-993 990 993 CS Tumor Size 994-995 994 995 CS Tumor Size 996 996 CS Tumor Size 997 997 CS Tumor Size 998 998 CS Tumor Size 999 999 000 ERROR M0 Tis M0 Tis M0 Tis M0 Tis M0 TX M0 ERROR M0 ERROR M1 Tis M0 100, 115-125, 230, 300 ERROR M0 T1 M0 T2 M0 T1 M0 T2 M0 TX M0 T4 M0 T4 M1 TX M0 110 ERROR M0 T1 M0 T1 M0 T1 M0 T1 M0 TX M0 T4 M0 T4 M1 T1 M0 200-220, 400-465 ERROR M0 T2 M0 T2 M0 T2 M0 T2 M0 TX M0 T4 M0 T4 M1 T2 M0 250 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 500-600, 730 ERROR M0 T3 M0 T3 M0 T3 M0 T3 M0 TX M0 T4 M0 T4 M1 T3 M0 610-720, 740-790 ERROR M0 T4 M0 T4 M0 T4 M0 T4 M0 TX M0 T4 M0 T4 M1 T4 M0 795 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 800-810 ERROR M0 T4 M0 T4 M0 T4 M0 T4 M0 TX M0 T4 M0 T4 M1 T4 M0 950 T0 M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M0 ERROR M1 ERROR M0 980-999 ERROR M0 TX M0 TX M0 TX M0 TX M0 TX M0 T4 M0 T4 M1 TX M0 Size Extension Mets SSF1 AJCC 6 Table CS SSF1 000, 988, or 999, CS Mets at DX 15,18,20,24 with CS Tumor Size and CS Extension Note: When CS Site-Specific Factor 1 is coded 000, 988, or 999, no separate tumor nodules in the primary site, unknown if separate nodules, or information not collected, and CS Mets at DX is coded 15, 18, 20, or 24, pleural effusion or pleural foci on one side or pericardial effusion, the values of T and M for AJCC 6 staging are assigned as shown in this table. The CS Mets at DX codes map to T4. The CS Site-Specific Factor 1 and CS Mets at DX codes map to M0. CS Tumor Size code 998, diffuse involvement of the entire lung, maps to M1. CS Extension CS Tumor Size 000 0 CS Tumor Size 001-997 1 997 CS Tumor Size 998 998 CS Tumor Size 999 999 000 ERROR M0 ERROR M0 ERROR M1 ERROR M0 100-230, 300-790, 800-810, 980-999 ERROR M0 T4 M0 T4 M1 T4 M0 250, 795 ERROR M0 ERROR M0 ERROR M1 ERROR M0 950 T4 M0 ERROR M0 ERROR M1 ERROR M0 Size Extension Mets SSF1 AJCC 6 Table CS SSF1 000, 988, or 999, CS Mets at DX 17,21,25,32,33,42,43,52,53 with CS Tumor Size and CS Extension Note: When CS Site-Specific Factor 1 is coded 000, 988, or 999, no separate tumor nodules in the primary site, unknown if separate nodules, or information not collected, and CS Mets at DX is coded 17, 21, 25, 32, 33, 42, 43, 52, or 53, metastatic involvement with pleural foci or pleural effusion involving the ipsilateral lung plus other distant involvement, the values of the T and M for AJCC 6 staging are assigned as shown in this table. The CS Mets at DX codes map to both T4 and M1. CS Extension CS Tumor Size 000 0 CS Tumor Size 001-999 1 999 000 ERROR M1 ERROR M1 100-230, 300-790, 800-810, 980-999 ERROR M1 T4 M1 250, 795 ERROR M1 ERROR M1 950 T0 M1 ERROR M1 Size Extension Mets SSF1 AJCC 6 Table CS SSF1 000, 988, or 999, CS Mets at DX 16, 23, 26, 30, 35, 36, 37, 38, 40, 41, 50, 51, 70, 75 with CS Tumor Size and CS Extension Note: When CS Site-Specific Factor 1 is coded 000 or 999, no separate tumor nodules in the primary site, unknown if separate nodules, or information not collected, and CS Mets at DX is coded 16, 23, 26, 30, 35, 36, 37, 38, 40, 50, 51, 70, 75, metastatic involvement without pleural foci or pleural effusion involving the ipsilateral lung, the values of the T and M for AJCC 6 staging are assigned as shown in this table. The T category is determined by the CS Tumor Size and CS Extension codes. The CS Mets at DX codes map to M1. CS Extension CS Tumor Size 000 0 CS Tumor Size 001-030 1 30 CS Tumor Size 031-989 31 989 CS Tumor Size 990-993 990 993 CS Tumor Size 994-995 994 995 CS Tumor Size 996 996 CS Tumor Size 997-998 997 998 CS Tumor Size 999 999 000 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 100, 115-125, 230, 300 ERROR M1 T1 M1 T2 M1 T1 M1 T2 M1 TX M1 T4 M1 TX M1 110 ERROR M1 T1 M1 T1 M1 T1 M1 T1 M1 T1 M1 T4 M1 T1 M1 200-220, 400-465 ERROR M1 T2 M1 T2 M1 T2 M1 T2 M1 TX M1 T4 M1 T2 M1 250 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 500-600, 730 ERROR M1 T3 M1 T3 M1 T3 M1 T3 M1 TX M1 T4 M1 T3 M1 610-720, 740-790 ERROR M1 T4 M1 T4 M1 T4 M1 T4 M1 TX M1 T4 M1 T4 M1 795 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 800-810 ERROR M1 T4 M1 T4 M1 T4 M1 T4 M1 TX M1 T4 M1 T4 M1 950 T0 M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 ERROR M1 980-999 ERROR M1 TX M1 TX M1 TX M1 TX M1 TX M1 T4 M1 TX M1 Size Extension Mets SSF1 AJCC 6 Table CS SSF1 000, 988, or 999, CS Mets at DX 99 with CS Tumor Size and CS Extension Note: When CS Site-Specific Factor 1 is coded 000, 988, or 999, no separate tumor nodules in the primary site, unknown if separate nodules, or information not collected, and CS Mets at DX is coded 99, unknown if pleural or pericardial effusion of pleural tumor foci and unknown if other metastatic disease, the values of T and M for AJCC 6 staging are assigned as shown in this table. The T category is determined by the CS Tumor Size and CS Extension codes. CS Tumor Size codes 997, diffuse involvement of lobe, and 998, diffuse involvement of the entire lung, both map to T4; code 998 also maps to M1. The CS Mets at DX code of 99 otherwise maps to MX. CS Extension CS Tumor Size 000 0 CS Tumor Size 001-030 1 30 CS Tumor Size 031-989 31 989 CS Tumor Size 990-993 990 993 CS Tumor Size 994-995 994 995 CS Tumor Size 996 996 CS Tumor Size 997 997 CS Tumor Size 998 998 CS Tumor Size 999 999 000 ERROR MX Tis MX Tis MX Tis MX Tis MX TX MX ERROR MX ERROR M1 Tis MX 100, 115-125, 230, 300 ERROR MX T1 MX T2 MX T1 MX T2 MX TX MX T4 MX T4 M1 TX MX 110 ERROR MX T1 MX T1 MX T1 MX T1 MX TX MX T4 MX T4 M1 T1 MX 200-220, 400-465 ERROR MX T2 MX T2 MX T2 MX T2 MX TX MX T4 MX T4 M1 T2 MX 250 ERROR MX ERROR MX ERROR MX ERROR MX ERROR MX ERROR MX ERROR MX ERROR MX ERROR MX 500-600, 730 ERROR MX T3 MX T3 MX T3 MX T3 MX TX MX T4 MX T4 M1 T3 MX 610-720, 740-790 ERROR MX T4 MX T4 MX T4 MX T4 MX TX MX T4 MX T4 M1 T4 MX 795 ERROR MX ERROR MX ERROR MX ERROR MX ERROR MX ERROR MX ERROR MX ERROR MX ERROR MX 800-810 ERROR MX T4 MX T4 MX T4 MX T4 MX TX MX T4 MX T4 M1 T4 MX 950 T0 MX ERROR MX ERROR MX ERROR MX ERROR MX ERROR MX ERROR MX ERROR M1 ERROR MX 980-999 ERROR MX TX MX TX MX TX MX TX MX TX MX T4 MX T4 M1 TX MX Size Extension Mets SSF1 AJCC 6 Table CS SSF1 000, 988, or 999, Mets at DX 10, 39 with Tumor Size and Extension Note: When CS Site-Specific Factor 1 is coded 000, 988, or 999, no separate tumor nodules in the primary site, unknown if separate nodules, or information not collected, and CS Mets at DX is code 10 or 39, OBSOLETE DATA CONVERTED codes in CSv2, the values of T and M for AJCC 6 staging are determined as shown in this table. CS Extension CS Tumor Size 000 0 CS Tumor Size 001-030 1 30 CS Tumor Size 031-989 31 989 CS Tumor Size 990-993 990 993 CS Tumor Size 994-995 994 995 CS Tumor Size 996 996 CS Tumor Size 997-998 997 998 CS Tumor Size 999 999 000 ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR 100, 115-125, 230, 300 ERROR ERROR T1 ERROR T2 ERROR T1 ERROR T2 ERROR TX ERROR T4 ERROR TX ERROR 110 ERROR ERROR T1 ERROR T1 ERROR T1 ERROR T1 ERROR TX ERROR T4 ERROR T1 ERROR 200-220, 400-465 ERROR ERROR T2 ERROR T2 ERROR T2 ERROR T2 ERROR TX ERROR T4 ERROR T2 ERROR 250 ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR 500-600, 730 ERROR ERROR T3 ERROR T3 ERROR T3 ERROR T3 ERROR TX ERROR T4 ERROR T3 ERROR 610-720, 740-790 ERROR ERROR T4 ERROR T4 ERROR T4 ERROR T4 ERROR TX ERROR T4 ERROR T4 ERROR 795 ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR 800-810 ERROR ERROR T4 ERROR T4 ERROR T4 ERROR T4 ERROR TX ERROR T4 ERROR T4 ERROR 950 T0 ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR 980-999 ERROR ERROR TX ERROR TX ERROR TX ERROR TX ERROR TX ERROR T4 ERROR TX ERROR Extension SSF1 AJCC 7 T Table CS SSF1 888 or 988 with CS Extension Note: When CS Site-Specific Factor 1 is coded 888 or 988 and CS Extension is coded 000-230, 300-440, 455-520, 540-600, 730, 950-980, 999, the T categories for AJCC 7 staging result in ERROR as shown in this table. CS Extension T Category 000-230, 300-440, 455-520, 540-600, 730, 950-999 ERROR Size Extension SSF1 AJCC 7 T Table CS SSF1 000 or 999 with CS Tumor Size and CS Extension Note: When CS Site-Specific Factor 1 is coded 000 or 999, no separate tumor nodules in the primary site or unknown if separate nodules, and CS Extension is coded 000-230, 300-440, 455-520, 540-600, 730, 950-980, 999, the value of T for AJCC 7 staging is assigned as shown in this table. The T category is determined by the CS Tumor Size and CS Extension codes. CS Tumor Size codes 997, diffuse involvement of lobe, and 998, diffuse involvement of the entire lung, map to T4. CS Extension CS Tumor Size 000 0 CS Tumor Size 001-020 1 20 CS Tumor Size 021-030 21 30 CS Tumor Size 031-050 31 50 CS Tumor Size 051-070 51 70 CS Tumor Size 071-989 71 989 CS Tumor Size 990-991 990 991 CS Tumor Size 992 992 CS Tumor Size 993 993 CS Tumor Size 994-995 994 995 CS Tumor Size 996 996 CS Tumor Size 997 997 CS Tumor Size 998 998 CS Tumor Size 999 999 000 ERROR Tis Tis Tis Tis Tis Tis Tis Tis Tis TX ERROR ERROR Tis 100, 230, 300 ERROR T1a T1b T2a T2b T3 T1a T1a T1b T2a TX T4 T4 TX 110 ERROR T1a T1a T1a T1a T1a T1a T1a T1a T1a TX T4 T4 T1a 115 ERROR T1a T1b T2a T2b T3 T1a T1a T1b T2a TX T4 T4 T1a 120 ERROR T1b T1b T2a T2b T3 T1b T1b T1b T2a TX T4 T4 T1b 125 ERROR T1NOS T1b T2a T2b T3 T1b T1b T1b T2a TX T4 T4 T1NOS 200, 210, 400, 410, 420, 430, 440 ERROR T2a T2a T2a T2b T3 T2a T2a T2a T2a TX T4 T4 T2NOS 220 ERROR T2a T2a T2a T2b T3 T2a T2a T2a T2a TX T4 T4 T2a 455 ERROR T2a T2a T2a T2b T3 T2a T2a T2a T2a TX T4 T4 T2a 460 ERROR T2b T2b T2b T2b T3 T2b T2b T2b T2b TX T4 T4 T2b 465 ERROR T2NOS T2NOS T2NOS T2b T3 T2NOS T2NOS T2NOS T2a TX T4 T4 T2NOS 500, 520, 540, 550, 560, 570, 590, 600, 730 ERROR T3 T3 T3 T3 T3 T3 T3 T3 T3 TX T4 T4 T3 950 T0 ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR 980 ERROR TX TX TX TX TX TX TX TX TX TX T4 T4 TX 999 ERROR TX TX TX TX TX TX TX TX TX TX T4 T4 TX Size Extension SSF1 AJCC 7 T Table CS SSF1 010-040 with CS Tumor Size and CS Extension Note: When CS Site-Specific Factor 1 is coded 010, 020, 030, or 040 and CS Extension is 000-230, 300-440, 455-520, 540-600, 730, 950-980, 999, the value of T for AJCC 7 staging is determined on the basis of CS Tumor Size, CS Extension, and CS Site-Specific Factor 1 as shown in this table. CS Site-Specific Factor 1 codes 010 and 040 indicate separate tumor nodules in same lobe or unknown if in same lobe, and map to T3, except for Tumor Size codes 997 and 998 which map to T4. CS Site-Specific Factor codes 020 and 030 indicate separate tumor nodules in different lobe or same and different lobes and map to T4. CS SSF 1 CS Tumor Size CS Extension 000-230, 300-440, 455-520, 540-600, 730, 950-980, 999 010 000-996, 999 T3 010 997-998 T4 020-030 000-999 T4 040 000-996, 999 T3 040 997-998 T4 Size Mets at DX AJCC 7 M Table CS Mets at DX Codes 00 and 99 Note: For CS Mets at DX codes 00 and 99, the M category for AJCC 7 staging is assigned based on the value of CS Tumor Size as shown in this table. CS Tumor Size CS Mets at DX 00 0 CS Mets at DX 99 99 000-997, 999 M0 M0 998 M1NOS M1NOS Extension SSF1 Summary Stage 77 Table Cases Coded in CSv2 (CS Version Input Original equals 02XXXX) or Year of Diagnosis is 2010 and After Note: For cases coded in CSv2 (CS Version Input Original equals 02XXXX) or Year of Diagnosis is 2010 and after, Stage 77 for CS Extension codes 000, 950, 980 and 999 is based on Extension and CS Site-Specific Factor 1. CS Site-Specific Factor 1 codes 000 and 999 map according to the extension value. CS Extension Code CS SSF1 000 0 CS SSF1 010 10 CS SSF1 020 20 CS SSF1 030 30 CS SSF1 040 40 CS SSF1 888 888 CS SSF1 988 988 CS SSF1 999 999 000 IS ERROR ERROR ERROR ERROR ERROR ERROR IS 950 U ERROR ERROR ERROR ERROR ERROR ERROR U 980 U ERROR ERROR ERROR ERROR ERROR ERROR U 999 U L L L L ERROR ERROR U Extension SSF1 Summary Stage 77 Table Cases Coded in CSv1 (CS Version Input Original Equals 01XXXX) and Year of Diagnosis is Less than 2010 Note: For cases coded in CSv1 (CS Version Input Original equals 01XXXX) and Year of Diagnosis is less than 2010, Summary Stage 77 for extension codes 000, 950, 980 and 999 is based on Extension and CS Site-Specific Factor 1. CS Site-Specific Factor 1 codes 000, 988 and 999 map according to the extension value. CS Site-Specific Factor 1 code 888 maps to ERROR. CS Site-Specific Factor 1 codes 010 and 040 are ERRORS with extension codes 950 and 980. CS Extension Code CS SSF1 000 0 CS SSF1 010 10 CS SSF1 020 20 CS SSF1 030 30 CS SSF1 040 40 CS SSF1 888 888 CS SSF1 988 988 CS SSF1 999 999 000 IS ERROR ERROR ERROR ERROR ERROR IS IS 950 U ERROR ERROR ERROR ERROR ERROR U U 980 U ERROR ERROR ERROR ERROR ERROR U U 999 U L L L L ERROR U U Extension SSF1 Summary Stage 2000 Table Cases Coded in CSv2 (CS Version Input Original equals 02XXXX) or Year of Diagnosis is 2010 and After Note: For CS Version 2 cases (CS Version Input Original equals 02XXXX) or Year of Diagnosis is 2010 and after, Summary Stage 2000 for CS Extension codes 000-700, 740, 950, 980 and 999 is based on CS Extension and CS Site-Specific Factor 1. CS Site-Specific Factor 1 codes 000 and 999 map according to the extension value. CS Site-Specific Factor 1 codes 010 and 040 indicate separate tumor nodules in same lobe or unknown if in same lobe, and map to Regional. CS Site-Specific Factor 1 codes 020 and 030, separate tumor nodules in different or separate tumor nodules in same and different lobe, map to Distant. CS Site-Specific Factor 1 codes 888 and 988 map to ERROR. CS Extension Code CS SSF1 000 0 CS SSF1 010 10 CS SSF1 020 20 CS SSF1 030 30 CS SSF1 040 40 CS SSF1 888 888 CS SSF1 988 988 CS SSF1 999 999 000 IS ERROR ERROR ERROR ERROR ERROR ERROR IS 100-230, 300 L RE D D RE ERROR ERROR L 250 ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR 400-650, 700 RE RE D D RE ERROR ERROR RE 680 L RE D D RE ERROR ERROR L 740 RE RE D D RE ERROR ERROR RE 950-999 U RE D D RE ERROR ERROR U Extension SSF1 Summary Stage 2000 Table Cases Coded in CSv1 (CS Version Input Original equals 01XXXX) and Year of Diagnosis is less than 2010 Note: For cases coded in CSv1 (CS Version Input Original equals 01XXXX) and a Year of Diagnosis date is less than 2010, Summary Stage 2000 for extension codes 000-700, 740, 950, 980 and 999 is based on Extension and CS Site-Specific Factor 1. CS Site-Specific Factor 1 codes 000, 988 and 999 map according to the extension value. CS Site-Specific Factor 1 code 888 maps to ERROR. CS Site-Specific Factor 1 codes 010 and 040 indicate separate tumor nodules in same lobe or unknown if in same lobe, and map to Regional. CS Site-Specific Factor 1 codes 020 and 030, separate tumor nodules in different or separate tumor nodules in same and different lobe, map to Distant. CS Extension Code CS SSF1 000 0 CS SSF1 010 10 CS SSF1 020 20 CS SSF1 030 30 CS SSF1 040 40 CS SSF1 888 888 CS SSF1 988 988 CS SSF1 999 999 000 IS ERROR ERROR ERROR ERROR ERROR IS IS 100-230, 300 L RE D D RE ERROR L L 250 ERROR ERROR ERROR ERROR ERROR ERROR ERROR ERROR 400-650, 700 RE RE D D RE ERROR RE RE 680 L RE D D RE ERROR ERROR L 740 RE RE D D RE ERROR RE RE 950-999 U RE D D RE ERROR U U